LRGF iShares U.S. Equity Factor ETF

Expense Ratio
0.08%
Dividend
1.22%
Previous close
$66.50
Est. 12 months change
+21.88%
Projected Price
$81.05

Profitability Metrics

Return on Equity (ROE)
44.35%
Return on Assets (ROA)
13.51%
Return on Invested Capital (ROIC)
38.99%
Weighted Average Cost of Capital (WACC)
9.30%
ROIC - WACC
29.69%
Updated : 2026-04-04 05:32 ET

Valuation Metrics

P/E Ratio
23.40
Forward P/E
18.14
PEG Ratio
1.98
Debt Current Ratio
1.71

Growth & Cash Flow

Gross Margin
55.59%
Operating Margin
29.29%
FCF Margin
24.02%
TTM Revenue Growth
18.15%
Projected 12M EPS Growth
29.01%

Price Change

Price % from 50 SMA
-2.59%
Price % from 200 SMA
-2.00%
6 Months
-4.15%
1 Year
13.44%
2 Years
24.67%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA7.08%
AAPL6.40%
MSFT4.43%
AMZN2.97%
AVGO2.73%
GOOG2.26%
META1.89%
JPM1.52%
TSLA1.38%
XOM1.31%

ETF Analysis

Fund Overview

iShares U.S. Equity Factor ETF (LRGF) currently reports 291 stock positions (subject to change), placing it in the broadly constructed range by holdings breadth. The top line-up is NVDA (7.08%), AAPL (6.40%), MSFT (4.43%), with NVDA as the largest single weight at 7.08%. Together, the top three holdings account for 17.91%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.

Profitability & Capital Efficiency

Looking at how effectively the underlying holdings deploy capital, ROIC is 38.99%, WACC is 9.30%, and the economic spread is 29.69%. On balance, holdings are earning returns on capital well in excess of what investors and creditors require — the defining characteristic of a high-quality compounding portfolio. Supporting metrics show ROE at 44.35% and ROA at 13.51%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

On an earnings multiple basis, trailing P/E of 23.40, forward P/E of 18.14, PEG of 1.98. The spread between trailing and forward P/E is moderate, suggesting some earnings improvement is expected but not a dramatic re-rating. The PEG ratio sits in a range that most investors would consider fair — neither cheap nor obviously stretched relative to anticipated earnings. A current ratio reading of 1.71 points to holdings that are managing short-term obligations without apparent stress. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.

Margins & Cash Generation

Across the three margin layers, gross margin sits at 55.59%, operating margin at 29.29%, and free cash flow margin at 24.02%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. Operating margins are in good shape, consistent with businesses that maintain reasonable earnings conversion after overhead. At this level, free cash flow margins suggest businesses that are building financial strength alongside revenue growth. Read together, these margins describe businesses that have earned their profitability rather than manufactured it through accounting — a meaningful quality signal.

Growth & Forward Outlook

Two key indicators frame the near-term view: TTM revenue growth of 18.15% a signal of steady demand without the volatility of high-growth names, while the estimated 12-month price change of 22.10%, where the target distribution indicates incremental upside rather than outsized repricing. The near-term return case is built on whether reported trends and analyst projections can remain close enough to make current prices look justified. Whether the setup resolves positively or negatively will depend as much on the macro backdrop as on the capacity of the underlying businesses to deliver against current estimates. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The full scorecard here is hard to argue with: capital efficiency is strong, margins are healthy, and growth is being priced constructively.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.